Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.

3 Mar 1990

Abstract excerpt

OBJECTIVE: To determine whether recombinant human erythropoietin improves the quality of life and exercise capacity of anaemic patients receiving haemodialysis. DESIGN: A double blind, randomised, placebo controlled study. SETTING: Eight Canadian university haemodialysis centres. PATIENTS: 118 Patients receiving haemodialysis aged 18-75 with haemoglobin concentrations less than 90 g/l, no causes of anaemia other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dialysis and Renal Disease Management
Share to Erythropoietin and Anemia Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 2108751
DOI: 10.1136/bmj.300.6724.573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.PMID 2108751Read ↗

Challenging patient phenotypes in the management of anaemia of chronic kidney disease.Semantic proximity Read ↗

Intradialytic cycling does not exacerbate microparticles or circulating markers of systemic inflammation in haemodialysis patients.Semantic proximity Read ↗

A pharmacodynamic model of erythropoietin therapy for uremic anemia.Semantic proximity Read ↗

Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes.Semantic proximity Read ↗

Telomere Shortening and HaemodialysisSemantic proximity Read ↗

Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in patients with end-stage renal failureSemantic proximity Read ↗

Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy.Semantic proximity Read ↗

Disparity in health-related quality of life between kidney transplant recipients and hemodialysis patients, and related implications for physical rehabilitation: A cross-sectional studySemantic proximity Read ↗

Should we ligate haemodialysis fistulas in patients once they have been transplanted successfully: a randomised feasibility study for a parallel randomised controlled trialSemantic proximity Read ↗

T-cell function, T-cell phenotype and its role in responsiveness to recombinant human erythropoietin in hemodialysis patients.Semantic proximity Read ↗

Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.Semantic proximity Read ↗

Phenotype, proliferation and apoptosis of B lymphocytes in hemodialysis patients treated with recombinant human erythropoietin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.